Tandem Diabetes Care (TNDM)

$94.17 0.41 (0.44%)

16:00 EDT TNDM Stock Quote Delayed 30 Minutes

Bret Kenwell

5 Top Stock Trades for Friday: SIG, MSFT, TNDM

By Bret Kenwell, InvestorPlace Contributor Jan 16, 2020

Signet Jewelers, Microsoft, Tandem Diabetes, InMode and Taiwan Semiconductor were our top stock trades for Friday -- and here's why.

8 Stocks to Buy That Are Growing Faster Than Amazon

10 Cheap Stocks to Buy Now

Why Tandem Diabetes Stock Will Rally Much Further

More Articles

Volume:

Previous Close -

Market Cap 5.90B

PE Ratio -122.30

EPS -0.77

Volume (Avg. Vol.) 483,575

Day's Range 92.01 - 94.74

52-Week Range 76.19 - 123.74

Dividend & Yield N/A (N/A)

TNDM Stock Predictions, Articles, and Tandem Diabetes Care News

From InvestorPlace
From the Web

5 Top Stock Trades for Tuesday: BAC, NFLX, ATVI, INTC

By Bret Kenwell, InvestorPlace Contributor Apr 1, 2019

Tandem Diabetes, Netflix, Activision Blizzard, Intel and Bank of America are our top stock trades to watch going into Tuesday.

Wait for the Inevitable Pullback to Buy TNDM Stock

By Will Healy, InvestorPlace Contributor Feb 28, 2019

TNDM stock should enjoy a bright, long-term future, but the quick run-up could mean Tandem Diabetes Care stock sees a near-term pullback.

5 Healthcare Stocks to Buy for Complete Portfolio Wellness

By Josh Enomoto, InvestorPlace Contributor Oct 10, 2018

Thanks to advancing technologies and a generally positive economy, healthcare stocks are back in the limelight.

Tandem Diabetes Is Firing on All Cylinders

By Chris Lau, InvestorPlace Contributor Sep 11, 2018

Tandem Diabetes sold shares of TNDM stock, but Tandem Diabetes stock continued to rocket higher. TNDM's Q2 results impressed investors, but its seasonally strong Q4 earnings could wow them more.

Why Tandem Stock Could Continue Its Rally

By Chris Lau, InvestorPlace Contributor Jun 25, 2018

Tandem stock rocketed to a new high after the company won an FDA approval and two analyst upgrades. At a one billion dollar market cap, the stock still has upside.

Tandem Diabetes Care Inc Is Up 194% — And It’s Not Done Yet

By Chris Lau, InvestorPlace Contributor Apr 13, 2018

Tandem Diabetes is firing on all cylinders and markets are already noticing. TNDM has more growth ahead than is currently priced into the stock.

4 Top Growth Picks as MedTech Battle Rages On

By Zacks Investment Research Oct 16, 2017

Trump’s Obamacare replacement saga has made growth picks great opportunities for investors in MedTech sector.

2 Unstoppable Growth Stocks That Can Make You Richer Than Dogecoin

From The Motley Fool Jun 13, 2021

These two companies are less volatile than the cryptocurrency, and they offer better long-term prospects, too.

Senseonics vs. Tandem: Which Diabetes Stock is a Better Buy?

From StockNews.com Jun 10, 2021

Given the rising number of people with diabetes, medical technology and devices that help diabetics live healthier lives are in great demand. Senseonics (SENS) and Tandem (TNDM) are two companies that focus on the treatment of diabetes. Which one of these stocks is a better buy now?

Tandem Diabetes Care Inc (TNDM) Q1 2021 Earnings Call Transcript

From The Motley Fool May 6, 2021

TNDM earnings call for the period ending March 31, 2021.

Custom Pre-earnings Bullish Diagonal Trigger in Tandem Diabetes Care Inc

From Capital Market Laboratories May 2, 2021

Custom Pre-earnings Bullish Diagonal Trigger in Tandem Diabetes Care Inc (NASDAQ:TNDM) Earnings.

Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021

From Benzinga May 25, 2021

Upgrades For Appian Corp (NASDAQ:APPN), Macquarie upgraded the previous rating of Underperform to Neutral. For the first quarter, Appian had an EPS of $0.06, compared to...

These 7 Medical Stocks Are Breaking Down — The Sell Rule You Should Know

From Investor's Business Daily May 13, 2021

Former high-flyers Dexcom and Tandem Diabetes are among seven health care stocks breaking down right now, according to MarketSmith.com.